- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Newstrike Resources announced it adjourned the hearing for a final court order related to the plan of arrangement relating to the acquisition by CanniMed Therapeutics of Newstrike.
Newstrike Resources (TSXV:HIP) announced it adjourned the hearing for a final court order related to the plan of arrangement relating to the acquisition by CanniMed Therapeutics (TSX:CMED) of Newstrike.
As quoted in the press release:
Newstrike Resources announces that pending the results of discussions among Aurora Cannabis and CanniMed Therapeutics, it has adjourned the hearing for the final court order in connection with the plan of arrangement relating to the acquisition by CanniMed of Newstrike, as specified in the Company’s management information circular dated December 12, 2017, available on SEDAR at www.sedar.com, until January 25, 2018.
The CanniMed special meeting of shareholders, which has been called to consider an ordinary resolution of the shareholders of CanniMed approving the issuance or reservation for issuance of such number of common shares of CanniMed as may be required pursuant to the Plan of Arrangement, is scheduled for January 25, 2018.
The Plan of Arrangement remains subject to approval of the shareholders of CanniMed at the meeting, court approval, applicable regulatory approvals, and the satisfaction of certain other closing conditions customary in transactions of this nature, as specified in the Management Information Circular.
Click here to read the full press release.
Source: www.weednewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.